As the data do not refute the possibility that tau and Aβ are on different pathways to synapse loss, a mouse model that expressed wild‐type human tau in the absence of mouse tau studied at multiple time points would be beneficial to studying the possible interaction between these two important molecules in the context of human AD and synapse loss. This evidence concerns the gene MAPT and Alzheimer disease.